Mail-In Semen Analysis Kit for Male Infertility
(EXPLORE Trial)

Recruiting in Palo Alto (17 mi)

Overseen byYanett Anaya, M.D.

Age: 18 - 65

Sex: Male

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: University of California, San Francisco

No Placebo Group

Trial Summary

What is the purpose of this trial?The investigators currently lack an understanding of barriers to completing the male factor infertility evaluation. Furthermore, as the investigators continue to expand access to fertility treatment particularly within low-resourced settings, it is important that all aspects of infertility within a couple are equally explored. The COVID-19 pandemic has disproportionately affected low-income communities and communities of color at greater rates in terms of not only disease morbidity/mortality but how medical systems are accessed and care is delivered.

Eligibility Criteria

This study is for English or Spanish speaking male partners of women undergoing infertility evaluations at Zuckerberg San Francisco General Hospital, who are recommended to have a semen analysis. Men must be over 18 years old and able to produce a semen sample.

Inclusion Criteria

I am a male partner of a patient at Zuckerberg San Francisco General Hospital, advised to have a semen analysis.

Exclusion Criteria

I do not speak English or Spanish.

Unable to produce a semen sample.

I am under 18 years old.

+1 more

Participant Groups

The trial is testing the use of mail-in semen analysis kits as part of the male infertility evaluation process, especially aimed at improving access in low-resourced settings affected by COVID-19.

2Treatment groups

Experimental Treatment

Active Control

Group I: No in-clinic semen analysis testingExperimental Treatment1 Intervention

Men needing semen analysis for infertility work-up.

Group II: In-Clinic Semen Analysis TestingActive Control1 Intervention

Men needing semen analysis for infertility work-up.